GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, KDR, MET, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
10.3224 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PPARA, SLC6A3, SRC, TYR |
8.92514 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.16648 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, SLC6A2, SLC6A3, SRC, TOP1, TYR |
8.16648 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, PPARA, SLC6A3, SRC, TYR |
8.16648 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A |
7.98435 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX5, ALPI, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRB, F10, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, HTR1A, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A2, SLC6A3, SRC, TOP1, TYR |
7.42634 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.42634 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.42634 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SLC6A3, SRC |
7.3116 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPI, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, MET, PPARA |
7.31071 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, SLC6A3, SRC, TOP2A, XDH |
7.136 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
6.91448 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FLT3, SLC6A3, SRC, TYR |
6.67549 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, HTR1A, SLC6A3, TYR |
6.67549 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, SRC, XDH |
6.56474 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F10, FLT3, GRM1, HCAR2, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
6.52627 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F10, FLT3, GRM1, HCAR2, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
6.50509 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, SRC, XDH |
6.46951 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, HMGCR, KDR, SLC6A3, SRC |
6.20807 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, HMGCR, HTR1A, SLC6A3, TYR |
6.06724 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
5.9045 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
5.89182 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC |
5.83221 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, HMGCR, KDR, SLC6A2, SLC6A3, SRC, TOP1 |
5.82544 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, SRC, TOP2A, XDH |
5.77997 |
[BP] GO:0007188 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A |
5.77997 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, PPARA, SRC, TOP1, TOP2A |
5.77584 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, SLC6A2, SLC6A3, SRC, TOP1, TOP2A, TYR |
5.509 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.38001 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F10, GRIK5, GRM5, HCAR2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SRC |
5.32987 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HMGCR, HSD17B1, HSD17B2 |
5.27493 |
[BP] GO:0007187 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A |
5.255 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MMP9, PIM1, SRC, TOP2A, XDH |
5.18219 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A |
5.18219 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, GRIK5, HTR1A, SLC1A1, SLC6A2, SLC6A3 |
5.18038 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
5.18038 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.18038 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
5.07412 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GLO1, HMGCR, PIM1, PPARA, TYR, XDH |
4.99882 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SRC, TYR |
4.93034 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
4.78703 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD2, GRM1, GRM3, GRM5, GRM8 |
4.75444 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP9, SRC, XDH |
4.5957 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.56219 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
4.56219 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SRC, TYR |
4.56219 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, F10, FLT3, GRM1, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
4.56219 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.42343 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, DRD2, DRD4, F10, FLT3, GRM1, HMGCR, KDR, MET, SRC, XDH |
4.39496 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.38349 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SRC |
4.37659 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.37219 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.37219 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.34208 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, DRD2, DRD3, DRD4, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
4.34208 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPI, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP1, TOP2A, TYR, XDH |
4.30667 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, DRD2, DRD3, DRD4, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
4.30329 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD2, DRD3, DRD4, HTR1A, SLC6A3 |
4.30329 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.25908 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, DRD3, ESR1, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 |
4.24722 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, F10, IGF1R, KDR, MET, MMP9, SRC |
4.22303 |
[BP] GO:0060078 |
None
|
ADORA1, DRD4, GRIA2, GRIA4, GRIK5, GRM5 |
4.22303 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
4.20799 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, MET, MMP9, SRC |
4.18937 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
4.18759 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP2A, XDH |
4.16886 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, ALPI, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, SLC6A3, SRC, TOP1, TOP2A, TYR, XDH |
4.11981 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
4.11981 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.11229 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.11229 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.06739 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESRRA, F10, FABP4, FLT3, GRM1, HMGCR, KDR, MET, MMP12, MMP2, MMP9, SRC, XDH |
4.06739 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.97958 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.94959 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD2, DRD3, HCAR2, HMGCR, KDR, SRC |
3.92934 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC |
3.92556 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, MET, MMP9, SRC |
3.92115 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.91007 |
[BP] GO:0007268 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.90101 |
[BP] GO:0098916 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.90101 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.89076 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.89076 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, ALPI, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FUT7, HMGCR, MET, PPARA |
3.89076 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.85089 |
[BP] GO:0099536 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.84576 |
[BP] GO:0099537 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.84576 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, SRC, TYR |
3.82394 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP2A, TYR |
3.76748 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, DRD4, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.76029 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA, TOP2A |
3.73564 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, SRC |
3.71834 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, GRM1, HMGCR, MMP2, PPARA, SRC, TYR |
3.71834 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX5, ALPI, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TOP1, TOP2A, TYR, XDH |
3.71834 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, SRC |
3.71834 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1, SLC6A2, SLC6A3 |
3.68748 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.68082 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, SLC6A3 |
3.66455 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, DRD2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, SRC |
3.61275 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, MET, MMP9, SRC |
3.59639 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.59639 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, SRC |
3.59447 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, TYR, XDH |
3.59447 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.5698 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.5561 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.5561 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, HMGCR, HTR1A, PPARA, SLC6A3 |
3.52967 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, PPARA, SRC |
3.5114 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.5114 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.5114 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.5111 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.49994 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, GRIK5, GRM5, HCAR2, HMGCR, HTR1A, MMP12, MMP9, PPARA, SRC |
3.49768 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.47628 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, GRM1, GRM5 |
3.47189 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, SRC |
3.46917 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESRRB, HCAR2, HMGCR, KDR, MET, MMP12, MMP9, PIM1, SLC1A1, SLC6A3, SRC |
3.4576 |
[BP] GO:0007626 |
None
|
APP, DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
3.45731 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, AOX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, DRD2, DRD3, DRD4, ESR1, F10, FLT3, FUT7, GLO1, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP1, TOP2A, TYR, XDH |
3.44188 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HCAR2, HMGCR, HTR1A, MMP12, SRC |
3.39943 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, SLC6A3 |
3.36455 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.36455 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD2, DRD4 |
3.33744 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, DRD2, DRD4, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
3.33744 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, DRD2, DRD4, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
3.33744 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.33035 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HMGCR, PPARA, SRC |
3.31375 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.28107 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.28107 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.2551 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.2551 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.2551 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.24304 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, DRD2, DRD4, ESRRB, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
3.2114 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.19839 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TOP1, TOP2A, XDH |
3.19839 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.19746 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, SRC |
3.19746 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SRC, XDH |
3.19746 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SRC, TOP2A, XDH |
3.18361 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.15087 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GRM5, HTR1A, MMP9 |
3.14971 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
3.14971 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HCAR2, HMGCR, HTR1A, MMP12, SRC |
3.14971 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, BCL2, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.13839 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.12318 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP1, TOP2A, XDH |
3.09003 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, MET, SRC, XDH |
3.07916 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SLC6A3, SRC, XDH |
3.07692 |
[BP] GO:0007267 |
None
|
ADORA1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.0515 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, SRC |
3.0515 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, BCL2, DRD2, DRD4, ESRRB, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
3.03833 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, DRD2, DRD4, FLT3, GRM1, HMGCR, KDR, SRC, XDH |
3.03833 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, DRD4, MMP9 |
3.03833 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, ESR1, HMGCR, IGF1R, MET, MMP9, SRC, XDH |
2.99783 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.96193 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.9555 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.9555 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, SLC6A3, SRC, XDH |
2.95222 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, BCL2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SRC, TOP2A, XDH |
2.9406 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.93384 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5 |
2.91418 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, ESR1, FABP4, HMGCR, KDR, MET, MMP12, PPARA, SLC6A3 |
2.91418 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SRC, TOP2A, XDH |
2.91418 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
2.91125 |
[BP] GO:0022898 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.90586 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.90586 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5 |
2.90586 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, GRM1, HCAR2, HMGCR, KDR, MET, MMP12, MMP9, PIM1, SLC1A1, SLC6A3, SRC, XDH |
2.90298 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.88386 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.88386 |
[BP] GO:0051588 |
None
|
DRD2, DRD3, DRD4, GRIK5, HTR1A |
2.87128 |
[BP] GO:1900542 |
None
|
DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, PPARA |
2.84831 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, BCL2, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
2.81204 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.80377 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SRC, TOP2A, XDH |
2.77511 |
[BP] GO:0006140 |
None
|
DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, PPARA |
2.77511 |
[BP] GO:0032409 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.76724 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPI, AOX1, APEX1, APP, AURKB, AXL, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP1, TOP2A, TYR, XDH |
2.76332 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, HCAR2, MMP12, SRC |
2.74552 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.73357 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.72693 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4 |
2.72693 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.71971 |
[BP] GO:0030817 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.71921 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.71825 |
[BP] GO:0008542 |
None
|
APP, DRD2, DRD3, HMGCR |
2.71496 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, DRD4, HCAR2, HMGCR, MMP12, SRC |
2.70777 |
[BP] GO:0023052 |
None
|
ADORA1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.70097 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.70097 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, SRC |
2.69 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GRM5, IGF1R, PPARA, SRC |
2.67496 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.6614 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.64685 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP2A, XDH |
2.62756 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.61369 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.61186 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, DRD2, DRD4, FLT3, GRM1, HMGCR, IGF1R, KDR, SRC, XDH |
2.6027 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CYP19A1, DRD2, DRD3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, SLC6A3, SRC, XDH |
2.58335 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, XDH |
2.58158 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, XDH |
2.57705 |
[BP] GO:0007632 |
None
|
APP, DRD2, DRD3, HMGCR |
2.5706 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.5706 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.56184 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
2.56184 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.56184 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.56184 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.56184 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.56184 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.56184 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.56184 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD4, HTR1A, SLC6A2 |
2.56184 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.56184 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.56184 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, SLC6A3, SRC, TYR |
2.56184 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.56184 |
[BP] GO:0042069 |
None
|
DRD4, HTR1A, SLC6A3 |
2.56184 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.56184 |
[BP] GO:0042053 |
None
|
DRD4, HTR1A, SLC6A3 |
2.56184 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, SRC, TOP2A |
2.55033 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, TOP1 |
2.54648 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, F10, FLT3, IGF1R, KDR, MET, SRC, TOP1, TOP2A |
2.54243 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.50465 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, SRC, XDH |
2.50465 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.50465 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.50465 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.47217 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.47197 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, HMGCR, PPARA, SLC6A3 |
2.4686 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, MMP12, SRC |
2.4686 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.46157 |
[BP] GO:0030814 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.45398 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.45058 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.45058 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.43128 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, BCL2, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, SRC, XDH |
2.42988 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.42318 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD2, DRD3, HMGCR, TYR |
2.42318 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MMP9, SRC, XDH |
2.41542 |
[BP] GO:0030802 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.41542 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, BCL2, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, HMGCR, HTR1A, SLC6A3, SRC, TYR |
2.41477 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, SRC, XDH |
2.41067 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.41067 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.41067 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.41067 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.41067 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.41067 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.41067 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.3868 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.3868 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.37884 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, APP, AXL, DRD2, DRD3, SLC1A1, SLC6A2, SLC6A3 |
2.37635 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.36467 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.36467 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.36467 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.36467 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, SRC, XDH |
2.36316 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.35418 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
2.35418 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A |
2.34761 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.34761 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.34761 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.34761 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, SRC |
2.34431 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.34018 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.33911 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.33493 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPI, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, SRC, TOP1, XDH |
2.33493 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.32867 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GRM5, IGF1R, SRC |
2.30974 |
[BP] GO:1900371 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.29828 |
[BP] GO:0030808 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.28365 |
[BP] GO:0048169 |
None
|
APP, DRD2, GRM5 |
2.28055 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.27062 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.26686 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.26434 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.25853 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.25807 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, DRD2, DRD3, DRD4, HCAR2, HMGCR, MMP12, SRC |
2.25474 |
[BP] GO:0042180 |
None
|
AKR1B1, CYP19A1, GLO1, HMGCR |
2.25105 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.25105 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD2, DRD3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, SRC, XDH |
2.24371 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP2A, XDH |
2.2437 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.2437 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.2437 |
[BP] GO:0050708 |
None
|
ACHE, DRD2, DRD3, DRD4, HCAR2, HMGCR, MMP12, SRC |
2.23868 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD2, DRD3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, SRC, XDH |
2.23662 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP2A, XDH |
2.22273 |
[BP] GO:0008306 |
None
|
APP, DRD2, DRD3, HMGCR |
2.21435 |
[BP] GO:0007612 |
None
|
APP, DRD2, DRD3, GRM5, HMGCR |
2.21435 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALPI, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2 |
2.20275 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.20275 |
[BP] GO:0032412 |
None
|
APP, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.1848 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.17482 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.17482 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.17482 |
[BP] GO:0030534 |
None
|
APP, DRD2, DRD3, DRD4, PPARA |
2.16683 |
[BP] GO:0034762 |
None
|
APP, BCL2, CA2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.15332 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, HCAR2 |
2.15288 |
[BP] GO:0030799 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.1425 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.13947 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F10, IGF1R, KDR, MET, MMP9, SRC |
2.13757 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, SLC6A3, SRC, TOP1, TOP2A, XDH |
2.13252 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPI, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, SRC, TOP1, XDH |
2.12914 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.12914 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.12914 |
[BP] GO:0051952 |
None
|
ADORA1, DRD2, DRD3, DRD4 |
2.12534 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9 |
2.12534 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, SRC |
2.12534 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HMGCR, SRC |
2.12534 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, HMGCR, SLC6A3 |
2.11464 |
[BP] GO:0046717 |
None
|
DRD2, DRD3, DRD4, SLC1A1 |
2.1075 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.09563 |
[BP] GO:0002209 |
None
|
BCL2, DRD4, HTR1A |
2.09563 |
[BP] GO:0001662 |
None
|
BCL2, DRD4, HTR1A |
2.09563 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.09563 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, IGF1R, KDR, MET, MMP1, MMP9, SRC |
2.09398 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, SRC |
2.07831 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.07204 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DRD4, FLT3, GRM1, HMGCR, IGF1R, SRC |
2.06421 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.05907 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.05907 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.05665 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F10, IGF1R, KDR, MET, MMP9, SRC |
2.05621 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.04719 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.04719 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.04719 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.04719 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.04719 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.04719 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.04719 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.04719 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.04719 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.04719 |
[BP] GO:0040018 |
None
|
BCL2, DRD2, SLC6A3 |
2.03758 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.03758 |
[BP] GO:0042596 |
None
|
BCL2, DRD4, HTR1A |
2.03758 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5 |
2.0339 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.01563 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.01563 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.01447 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
APP, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, HMGCR, IGF1R, MMP9, SRC |
2.00894 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, CYP1A1, CYP1B1, ESR1, FLT3, SRC |
2.00894 |
[BP] GO:0010907 |
None
|
ESRRB, PPARA, SRC |
2.00548 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F10, IGF1R, KDR, MET, MMP9, SRC |
2.00066 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, DRD2, DRD3, DRD4, F10, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
5.99371 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPI, APP, AXL, CA12, CA14, CA2, CA4, CSNK2A1, DRD2, DRD3, DRD4, ESR1, F10, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, IGF1R, KDR, MET, MMP2, PIM1, SLC1A1, SLC6A2, SLC6A3, SRC |
5.05563 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
5.01006 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC |
4.5957 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, APP, AXL, CA2, CA4, DRD2, DRD3, DRD4, F10, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC |
4.22303 |
[CC] GO:0098794 |
None
|
ADORA1, APP, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
3.80734 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPI, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP2, PIM1, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
3.57189 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.49994 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
3.47628 |
[CC] GO:0043197 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.38546 |
[CC] GO:0044309 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.35094 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
3.2551 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.21909 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.21909 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPI, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
3.16585 |
[CC] GO:0009330 |
None
|
TOP1, TOP2A |
2.93384 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.41623 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.41256 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A2, SLC6A3, SRC, TOP1 |
2.38384 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.17482 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, ALPI, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TYR, XDH |
11.1585 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPI, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TOP1, TOP2A, TYR, XDH |
9.57187 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.04706 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.87253 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, IGF1R, KDR, MET, PPARA |
7.78623 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPI, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, HTR1A, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, TOP2A, TYR, XDH |
7.136 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, IGF1R, KDR, MET, PPARA |
6.91958 |
[MF] GO:0030594 |
None
|
DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR1A |
6.91448 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, IGF1R, KDR, MET, PPARA |
6.69986 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, IGF1R, KDR, MET, PPARA |
6.23209 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.46327 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA |
5.30697 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, IGF1R, KDR, MET |
5.05563 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, IGF1R, KDR, MET |
5.05563 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.92685 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPI, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, TOP2A, TYR, XDH |
4.65978 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.56219 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, TYR, XDH |
4.39248 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPI, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TOP1, TOP2A, TYR, XDH |
4.37659 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A3, SRC, TOP1, TOP2A |
4.37219 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, HTR1A, SLC6A3 |
4.31653 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
4.27203 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, CBR1, HMGCR, HSD17B1, HSD17B2, XDH |
4.05928 |
[MF] GO:1901338 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.92547 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.89076 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.89076 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.73504 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.68903 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DRD2, DRD4, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KDR, MET, MMP9, TOP2A, TYR, XDH |
3.66606 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.5698 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.5698 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.5114 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.49994 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, SLC6A3, SRC |
3.21909 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.0872 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.0515 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
2.93806 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.93384 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, SLC6A3, SRC |
2.87525 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.80377 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.77014 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.56184 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.56184 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.56184 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.56184 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.56184 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.56184 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, SRC, XDH |
2.54649 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, CBR1, HMGCR, HSD17B1, HSD17B2 |
2.41542 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.34761 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.34761 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.34018 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.31177 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, HSD17B1, PPARA |
2.2437 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.18803 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.17482 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, SLC6A3 |
2.16517 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A |
2.04719 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.04719 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.04719 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.04719 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.01447 |